£8.7M
The funding round included participation from XTX Ventures and Macmillan Cancer Support to accelerate deployment and expand diagnostics.
Lucida Medical
Lucida Medical develops artificial intelligence software to accelerate and improve cancer diagnostics from MRI scans.
£10.7MTotal raised
Lucida Medical is a healthtech company that develops artificial intelligence software to help clinicians detect prostate cancer and other conditions from MRI scans.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Shareholders' funds
Members only
Current assets
Members only
Profit for the year
Members only
Cash, assets and headcount from Lucida Medical's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
Evis Sala
Chief Medical Officer
Evis co-founded Lucida Medical and served as its Chief Medical Officer. She has held academic and clinical roles at the University of Cambridge, Weill Cornell Medicine, and Università Cattolica del Sacro Cuore, alongside serving as Minister of Health and Social Protection in Albania.
LinkedInAR
Investors
- £8.7M
- £2.0M
Funding history
£2.0M
The seed round was led by XTX Ventures and Prostate Cancer Research to support regulatory approvals and clinical studies.